Cargando…
Possibility of COVID-19 eradication with evolution of a new omicron variant
COVID-19 has been a global health concern since 2019 until date. Global concerted efforts to combat this pandemic has resulted in a number of vaccines distributed across the globe. Although the presence of these vaccines produced quick interventions, dynamic mutation in the causal virus and the cont...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919351/ https://www.ncbi.nlm.nih.gov/pubmed/35287739 http://dx.doi.org/10.1186/s40249-022-00951-7 |
_version_ | 1784668927299682304 |
---|---|
author | Okpeku, Moses |
author_facet | Okpeku, Moses |
author_sort | Okpeku, Moses |
collection | PubMed |
description | COVID-19 has been a global health concern since 2019 until date. Global concerted efforts to combat this pandemic has resulted in a number of vaccines distributed across the globe. Although the presence of these vaccines produced quick interventions, dynamic mutation in the causal virus and the continuous evolution of new stains that defy available vaccines has given rise to pertinent questions. The most recent emergence of a new COVID-19 virus variant (omicron), the rapid spread and overwhelming rate of morbidity and mortality has reopened these questions for debate. This commentary summarizes major view on these questions and concludes that multiple approach including social behavioural measures, vaccination and antiviral drug would speed up elimination process. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-8919351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89193512022-03-14 Possibility of COVID-19 eradication with evolution of a new omicron variant Okpeku, Moses Infect Dis Poverty Commentary COVID-19 has been a global health concern since 2019 until date. Global concerted efforts to combat this pandemic has resulted in a number of vaccines distributed across the globe. Although the presence of these vaccines produced quick interventions, dynamic mutation in the causal virus and the continuous evolution of new stains that defy available vaccines has given rise to pertinent questions. The most recent emergence of a new COVID-19 virus variant (omicron), the rapid spread and overwhelming rate of morbidity and mortality has reopened these questions for debate. This commentary summarizes major view on these questions and concludes that multiple approach including social behavioural measures, vaccination and antiviral drug would speed up elimination process. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2022-03-14 /pmc/articles/PMC8919351/ /pubmed/35287739 http://dx.doi.org/10.1186/s40249-022-00951-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Okpeku, Moses Possibility of COVID-19 eradication with evolution of a new omicron variant |
title | Possibility of COVID-19 eradication with evolution of a new omicron variant |
title_full | Possibility of COVID-19 eradication with evolution of a new omicron variant |
title_fullStr | Possibility of COVID-19 eradication with evolution of a new omicron variant |
title_full_unstemmed | Possibility of COVID-19 eradication with evolution of a new omicron variant |
title_short | Possibility of COVID-19 eradication with evolution of a new omicron variant |
title_sort | possibility of covid-19 eradication with evolution of a new omicron variant |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919351/ https://www.ncbi.nlm.nih.gov/pubmed/35287739 http://dx.doi.org/10.1186/s40249-022-00951-7 |
work_keys_str_mv | AT okpekumoses possibilityofcovid19eradicationwithevolutionofanewomicronvariant |